Ananda Developments

Directors

Shareholders

Announcements

Publications

Broker Coverage

Company and Advisors

Corporate Governance

Home

Updates

Investment Opportunity

Ubuntu

Ananda Developments plc (AQSE: ANA), a life sciences company focused on the research and development of CBD-based therapies for a range of complex inflammatory pain conditions, has today released a whitepaper entitled ‘An introduction to Cannabidiol (CBD) as a Pharmaceutical Medicine’.

The report provides a comprehensive overview of CBD's potential therapeutic reach. Despite a growing body of anecdotal evidence and preclinical research, there remains a critical gap in robust clinical data to fully understand CBD's efficacy and safety for various medical conditions.